/R E P E A T -- Media advisory - Announcement of a $3 M partnership between the Canadian Cancer Society and the Cole Foundation to create a better convergence among Montreal research centres specializing in pediatric cancer/

  • Even if pediatric cancers represent less than 1% of all cancers diagnosed in Canada, they are very important from a public health perspective.
  • Cancer is the leading cause of death by disease for children in the country.
  • Leukemia and lymphoma alone will account for more than 40% of childhood cancer cases diagnosed in 2015.

MONTREAL, Nov. 23, 2015 /CNW Telbec/ -


Announcement of pediatric cancer research fund that will promote the emergence of new ideas in research on leukemia and lymphoma in children and young adults. The initiative will also encourage the creation of new teams of researchers and clinicians from different research institutions in Montreal (and possibly from outside Montreal).


Tuesday, November 24th, 2015

10:30 am


Canadian Cancer Society

5151 de l'Assomption Blvd., Montreal


  • Suzanne Dubois, Executive Director, Canadian Cancer Society – Quebec Division
  • Barry Cole, CEO and Board Chair of the Cole Foundation
  • Dr Jean-Sébastien Delisle, researcher, haematologist and co-director of the Centre of Excellence for Cellular Therapy at the Maisonneuve-Rosemont Hospital*
  • Nadine Maltais, now 18 years old, who was diagnosed with leukemia at age 13.

* It will be possible to take images of Dr Delisle's laboratory at the Maisonneuve-Rosemont Hospital after the press event.


SOURCE Canadian Cancer Society, Quebec Division

For further information: André Beaulieu, Spokesperson and Senior Advisor, Communication, Canadian Cancer Society - Quebec Division, 514 393-3444, abeaulieu@quebec.cancer.ca

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890